These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 17975550)
1. Mutant huntingtin can paradoxically protect neurons from death. Zuchner T; Brundin P Cell Death Differ; 2008 Mar; 15(3):435-42. PubMed ID: 17975550 [TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303 [TBL] [Abstract][Full Text] [Related]
3. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753 [TBL] [Abstract][Full Text] [Related]
4. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat. Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331 [TBL] [Abstract][Full Text] [Related]
5. The early cellular pathology of Huntington's disease. Li XJ Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117 [TBL] [Abstract][Full Text] [Related]
6. Selective degeneration in YAC mouse models of Huntington disease. Van Raamsdonk JM; Warby SC; Hayden MR Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936 [TBL] [Abstract][Full Text] [Related]
8. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Bradford J; Shin JY; Roberts M; Wang CE; Li XJ; Li S Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22480-5. PubMed ID: 20018729 [TBL] [Abstract][Full Text] [Related]
9. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600 [TBL] [Abstract][Full Text] [Related]
10. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease. Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963 [TBL] [Abstract][Full Text] [Related]
11. [Huntington disease. A review]. Bonilla E Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047 [TBL] [Abstract][Full Text] [Related]
12. Transgenic rat model of Huntington's disease. von Hörsten S; Schmitt I; Nguyen HP; Holzmann C; Schmidt T; Walther T; Bader M; Pabst R; Kobbe P; Krotova J; Stiller D; Kask A; Vaarmann A; Rathke-Hartlieb S; Schulz JB; Grasshoff U; Bauer I; Vieira-Saecker AM; Paul M; Jones L; Lindenberg KS; Landwehrmeyer B; Bauer A; Li XJ; Riess O Hum Mol Genet; 2003 Mar; 12(6):617-24. PubMed ID: 12620967 [TBL] [Abstract][Full Text] [Related]
13. Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Yang D; Wang CE; Zhao B; Li W; Ouyang Z; Liu Z; Yang H; Fan P; O'Neill A; Gu W; Yi H; Li S; Lai L; Li XJ Hum Mol Genet; 2010 Oct; 19(20):3983-94. PubMed ID: 20660116 [TBL] [Abstract][Full Text] [Related]
14. Huntington's disease: from molecular pathogenesis to clinical treatment. Ross CA; Tabrizi SJ Lancet Neurol; 2011 Jan; 10(1):83-98. PubMed ID: 21163446 [TBL] [Abstract][Full Text] [Related]
15. Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease. Sutton LM; Sanders SS; Butland SL; Singaraja RR; Franciosi S; Southwell AL; Doty CN; Schmidt ME; Mui KK; Kovalik V; Young FB; Zhang W; Hayden MR Hum Mol Genet; 2013 Feb; 22(3):452-65. PubMed ID: 23077216 [TBL] [Abstract][Full Text] [Related]
16. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Milnerwood AJ; Cummings DM; Dallérac GM; Brown JY; Vatsavayai SC; Hirst MC; Rezaie P; Murphy KP Hum Mol Genet; 2006 May; 15(10):1690-703. PubMed ID: 16600988 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of neuronal cell death in Huntington's disease. Sawa A; Tomoda T; Bae BI Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190 [TBL] [Abstract][Full Text] [Related]
18. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478 [TBL] [Abstract][Full Text] [Related]
19. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219 [TBL] [Abstract][Full Text] [Related]
20. Orexin loss in Huntington's disease. Petersén A; Gil J; Maat-Schieman ML; Björkqvist M; Tanila H; Araújo IM; Smith R; Popovic N; Wierup N; Norlén P; Li JY; Roos RA; Sundler F; Mulder H; Brundin P Hum Mol Genet; 2005 Jan; 14(1):39-47. PubMed ID: 15525658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]